See the full GHRP-2 Benefits Guide for a deeper look at its research-backed effects
doi:10.1046/j.1432-1327.2000
In recent years, a class of diabetes and weight loss medications called Glucacon-Like Peptide-1 Receptor Agonists (often referred to as GLP-1s and semaglutide) have transformed the landscape of weight management and type 2 diabetes care
The downstream effects include activation of hormone-sensitive lipase in adipose tissue (which breaks down stored triglycerides into free fatty acids), increased protein synthesis in skeletal muscle, enhanced cellular repair and turnover, elevated IGF-1 production from the liver, and improved lipid metabolism including reduced triglycerides
Detoxification capacity drops, reactive oxygen species accumulate, inflammatory cascades escalate, mitochondrial ATP production becomes inefficient, and immune surveillance weakens